Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

28 Oct 2020

Italy pledges first EUR 5 million funding to CEPI to advance COVID-19 vaccine development efforts
Financial contribution is part of a larger donation to support CEPI's work.

Read more

Read article

23 Oct 2020

USA joins CEPI to support the development of epidemic vaccines
A total of US$20 million will be provided to CEPI through USAID to support programmes advancing vaccines against emerging infectious diseases

Read more

21 Oct 2020

CEPI expands global manufacturing network, reserving manufacturing capacity for more than 1 billion doses of COVID-19 vaccines
CEPI has signed agreements with Biofabri (Spain) and GC Pharma (Republic of Korea) to reserve vaccine manufacturing capacity for more than 1 billion doses of COVID-19 vaccines designated by CEPI.

Read more

20 Oct 2020

Two more laboratories join CEPI’s centralised network to standardise assessment of COVID-19 vaccines
The NIBSC and Q2 Solutions will work alongside five other laboratories, using the same testing reagents and following common protocols, for uniform evaluation and direct comparisons of COVID-19 vaccine candidates.

Read more

14 Oct 2020

Private sector companies provide financial support for CEPI’s COVID-19 vaccine programmes
Donations from companies including Nestlé, Beiersdorf, and Sumitomo Mitsui Financial Group, Inc. (SMFG), will help advance the development of CEPI-funded COVID-19 vaccine candidates.

Read more

02 Oct 2020

Why and how do we harmonise assessment of COVID-19 vaccine trials?
Valentina Bernasconi, Preclinical and Immunology Scientist at CEPI and Project Leader of the Centralised Laboratory Network, discusses the importance of centralising the analysis of samples obtained from trials of COVID-19 vaccines and how CEPI has launched a global network of laboratories to address this challenge.

Read more

02 Oct 2020

CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
All COVID-19 vaccine developers can use the network of five laboratories working together as part of centralised network to reliably assess and compare immunological responses generated by COVID-19 vaccine candidates

Read more

28 Sep 2020

Why we need a “portfolio approach” to COVID-19 vaccine development
Hundreds of vaccine candidates against COVID-19 are under development. Predicting which of these will be successful is extremely difficult. That’s why we need multiple shots at goal, writes Nick Jackson, Head of Programmes and Innovative Technology at CEPI.

Read more

Read article

21 Sep 2020

Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX Facility
64 higher income economies have now joined the COVAX Facility, with a further 38 economies expected to sign in the coming days

Read more

18 Sep 2020

COVAX: A Moment of Truth in the Pandemic
To succeed, COVAX requires broad international buy-in, based on the recognition that no one is safe until everyone is.

Read more

04 Sep 2020

321 vaccine candidates against COVID-19 now in development
CEPI report analyses the global progress that has been made in the search for a COVID-19 vaccine

Read more

©2020 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.